Market Research Logo

PRPF – Petten Pallas Reactor – North Holland - Project Profile

1.Key Statistics
2.Key Dates
3.Sector
4.Tender Information
5.Scope
6.Description
7.Latest update
8.Background
9.Key Contacts
10.General News, Project News
11.Appendix

PRPF – Petten Pallas Reactor – North Holland - Project Profile

Synopsis

"PRPF – Petten Pallas Reactor – North Holland - Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts.

The "PRPF – Petten Pallas Reactor – North Holland - Project Profile" is part of Timetric's database of 82,000+ construction projects. Our database includes a 10+ year archive of completed projects, full coverage of all global projects with a value greater than $25 million and key contact details for project managers, owners, consultants, contractors and bidders.

Summary

Pallas Reactor Preparation Foundation (PRPF) is undertaking the Petten Pallas Reactor project in North Holland, the Netherlands.

The project involves the replacement of a high flux pool type reactor. The project will be developed in three phases: the licensable design phase, the realisation phase and the operational phase.

The main functions of PALLAS would be the production of medical isotopes, irradiation with neutrons for technical and scientific research, training and education.

In 2008, three companies bid to supply the reactor: Areva NP, INVAP and Korea Atomic Energy Research Institute (KAERI) (with Korea Power Engineering and Doosan), but no funds were available then and the bids lapsed in 2010.

Ten Haaf en Bakker and Van der Goes en Groot have been appointed to undertake the study for development.

Energy Research Centre of the Netherlands (ECN) has been appointed as an associated developer.

On April 11, 2012, study activities were commenced and completed in July 2013.

Royal HaskoningDHV has been appointed to provide the architecture and landscaping expertise for the project.

In July 2013, European Commission had concluded that a loan of US$105 million will be granted by the Dutch authorities to support the construction activities of the project.

In December 16, 2013, the project is housed in an independent foundation PRPF from NRG.

In May 2015, Tractebel Engineering was appointed to provide technical and project management personnel to support Palla.

In October 2015, the provincial government of North Holland canceled the second installment of the loan after concerns were raised regarding the feasibility.

In January 2016, zoning amendment procedure started.

In the year 2016, PRPF re-initiated the pre-qualification process and qualified three bidders. The pre-qualified consortia include Consortium of Invap; Consortium of Areva; Consortium of Korea Atomic Energy Research Institute (KAERI).

In the fourth quarter of 2016, tenders were invited from the pre-qualified consortia, with a submission deadline of March 2017. All the three consortia participated the tender process.

On January 24, 2018, PRPF was awarded design and construction contract to Ichos consortium which includes Invap along with Croonwolter&dros and Mobilis, both part of TBI Holdings of the Netherlands.

Design works are underway.

Scope

The project involves the construction of a high flux nuclear reactor which will be responsible for the production of medical isotopes in Petten, North Holland, the Netherlands.

The US$645 million project includes the following:

1. Replacement of a nuclear reactor

2. Construction of related safety facilities

3. Construction of power house

4. Installation of machinery and equipmentReasons To Buy

  • Gain insight into the project.
  • Monitor the latest project developments.
  • Identify key project contacts.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;